Literature DB >> 23803943

Stem cells: bad seeds.

Cassandra Willyard.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23803943     DOI： 10.1038/498S12a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

Authors:  Geoffrey L Uy; Michael P Rettig; Ibraheem H Motabi; Kyle McFarland; Kathryn M Trinkaus; Lindsay M Hladnik; Shashikant Kulkarni; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Ravi Vij; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

2.  Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

Authors:  Max Jan; Thomas M Snyder; M Ryan Corces-Zimmerman; Paresh Vyas; Irving L Weissman; Stephen R Quake; Ravindra Majeti
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

3.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

4.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

5.  A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.

Authors:  Yoriko Saito; Hitomi Yuki; Mitsuo Kuratani; Yoshinobu Hashizume; Shinsuke Takagi; Teruki Honma; Akiko Tanaka; Mikako Shirouzu; Junko Mikuni; Noriko Handa; Ikuko Ogahara; Akiko Sone; Yuho Najima; Yuri Tomabechi; Motoaki Wakiyama; Naoyuki Uchida; Mariko Tomizawa-Murasawa; Akiko Kaneko; Satoshi Tanaka; Nahoko Suzuki; Hiroshi Kajita; Yuki Aoki; Osamu Ohara; Leonard D Shultz; Takehiro Fukami; Toshio Goto; Shuichi Taniguchi; Shigeyuki Yokoyama; Fumihiko Ishikawa
Journal:  Sci Transl Med       Date:  2013-04-17       Impact factor: 17.956
  5 in total
  4 in total

Review 1.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

2.  Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.

Authors:  Xiaoti Lin; Weiyu Chen; Fengqin Wei; Binhua P Zhou; Mien-Chie Hung; Xiaoming Xie
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556

3.  Heterogeneity of functional properties of Clone 66 murine breast cancer cells expressing various stem cell phenotypes.

Authors:  Partha Mukhopadhyay; Tracy Farrell; Gayatri Sharma; Timothy R McGuire; Barbara O'Kane; J Graham Sharp
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

Review 4.  The role of interleukin-6-STAT3 signalling in glioblastoma.

Authors:  Alice J West; Vanessa Tsui; Stanley S Stylli; Hong P T Nguyen; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  Oncol Lett       Date:  2018-07-27       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.